In this issue:
Roflumilast cream for chronic plaque psoriasis
Skin psoriasis, somatic comorbidity and development of psychiatric illness
New-onset IBD after IL-17 inhibitors
Eczema in patients receiving biologics for plaque psoriasis
Cardiovascular and metabolic risk factors in adolescents with psoriasis
Brodalumab in patients with prior exposure or inadequate response to biologics
Psoriasis and atopic dermatitis characteristics in adults
Guselkumab for active PsA (Discover 2)
Guselkumab for active PsA (Discover 1)
Please login below to download this issue (PDF)